Safety and effectiveness of Cabtreo for moderate to severe acne
Part of Skin clinical trials.
This study tests a new acne treatment called Cabtreo in children and young teens ages 9–11. The treatment combines three ingredients to reduce acne bumps and spots on the face and body.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 9 and 11 years, 11 months old
- You must have moderate or severe acne with many bumps (at least 30), blackheads or whiteheads (at least 35), and acne on your chest, back, or shoulders
- You must not be pregnant or nursing, and if you could become pregnant, you must use birth control during the study
- You must not have used other acne medicines, antibiotics, or steroid creams on your face within 2–4 weeks before the study starts
- You must not have other skin conditions like eczema or rosacea on your face that could interfere with the study
- You must be willing to use only study-approved cleansers, moisturizers, and sunscreens during the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is testing a new spray called B244 that you put on your face to help treat moderate to severe acne. It aims to see if it is safe, works well, and is comfortable to use.
This study tests a new cream (clascoterone) for moderate to severe acne. The cream is applied to the face to reduce pimples and is compared to a placebo (a cream without the active ingredient).
This trial studies whether putting antibiotic creams on mild-to-moderate facial acne reduces inflammation. It may help answer whether topical erythromycin or clindamycin can improve acne-related redness and swelling.
This trial tests a new cream called clascoterone for moderate to severe facial acne. It may help reduce pimples and blackheads with fewer side effects than some other treatments.
This trial tests a weekly dose of isotretinoin (a strong acne medicine) versus a standard tetracycline antibiotic for treating moderate acne. It aims to find a simpler, effective option with fewer side effects.
This trial tests a new combination hormonal pill (a progestogen and low-dose estrogen) to treat moderate acne in women. It may be an option if you have not had success with other acne treatments.
Hear when a new Acne Vulgaris trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.